Publication | Closed Access

Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes

Metabolic SyndromeNeurodegenerative DiseasesAlzheimer's DiseaseMedicineInsulin ManagementDiabetesNeuronal Insulin ResistanceNeuropharmacologyNeuroprotectionNeuroscienceNeurologyPharmacologyInsulin Signaling